MDMG — Mother and child
AI预测: MDMG
AI发布下一个交易日、周末和月末的目标价。涨跌幅以最新价格计算。这些是统计估计，而非投资建议。
近6个月价格
Premium会员可查看该股票及所有其他股票的1天、1周和1个月AI目标价。
解锁Premium🔒 预测记录
预测记录（每次过往预测与实际收盘价对照）为Premium功能。
解锁Premium关于该公司
Mater and Ditya is one of the leaders of the Russian private healthcare market. Founded in 2006 by obstetrician-gynecologist Mark Kurtser, the company now holds a leading position in Russia in the field of women’s and children’s health. The company’s assets include 11 high-tech hospitals, 44 clinics, and one medical university. The medical facilities specialize in a broad range of healthcare services, providing care in reproductive medicine, women’s health, and pediatrics, as well as in the treatment of socially significant diseases, including oncology and cardiology. In 2022, the company ranked second in Forbes’ “Top 20 Medical Companies – 2022” ranking, with revenue of RUB 25 billion.
